The landscape of dementia prognosis has progressed significantly with the advent of refined biomarkers, like amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology a long time just before signs and symptoms arise. Though these technological advancements symbolize impressive progress in knowing neurodegenerative illnesses, they have https://josuewhrbl.blogsumer.com/37119737/the-enduring-price-of-cognitive-evaluation-for-older-older-people